➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Dow
McKesson
Johnson and Johnson
McKinsey

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

Litigation Details for Eko Brands v. Adrian Rivera Maynez Enterprises Inc (W.D. Wash. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Eko Brands v. Adrian Rivera Maynez Enterprises Inc (W.D. Wash. 2015)

Docket   Start Trial Date Filed 2015-04-02
Court District Court, W.D. Washington Date Terminated 2018-07-13
Cause 15:1126 Patent Infringement Assigned To Michelle L. Peterson
Jury Demand Plaintiff Referred To
Parties ADRIAN RIVERA; ADRIAN RIVERA MAYNEZ ENTERPRISES INC; EKO BRANDS. LLC
Patents 6,962,700; 8,022,082
Attorneys D Jeffrey Burnham; David Allen Lowe; John Fuisz; Matthew Cunningham; Philip P Mann; Sudip Kundu; Timothy J Billick; William A Delgado
Firms Christensen O'Connor Johnson & Kindness; Dto Law; Johnson Graffe Keay Moniz & Wick (Sea); Kundu PLLC; Lowe Graham Jones Pllc; Mann Law Group Pllc; The Fuisz-Kundu LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Eko Brands v. Adrian Rivera Maynez Enterprises Inc
The small molecule drug covered by the patents cited in this case is   Start Trial .
Biologic Drugs cited in Eko Brands v. Adrian Rivera Maynez Enterprises Inc
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for Eko Brands v. Adrian Rivera Maynez Enterprises Inc (W.D. Wash. 2015)

Date Filed Document No. Description Snippet Link To Document
2018-05-30 218 Pretrial Order ARM-D.Ct.- X Aprill 8- 000016 to ARM-D.Ct.- Aprill 8- 000022 82. Printout of NA https://www.walmart.com/ip/Solofill-KZ…claims 8 and 19 of ARM’s U.S. Patent No. 8,720,320 (“the 320 patent”) patent are invalid as obvious under…of the 855 patent. 4. U.S. Patent Application No. 11/777,831, which led to the 320 patent was filed on…deemed patentable over ARM’s 320 patent, as well as the 303 application to Robert Vu. 10. The Patent Office…certificate of the 855 patent NA X 4. U.S. Patent No. 8,561,524 ' NA X 5. U.S. Patent No. D688,095 NA X External link to document
2020-04-23 350 3 - Stipulation and Order Adrian Rivera Maynez Enters., 2020 U.S. App. LEXIS 962 (Fed. Cir. Jan. 13, 2020). The parties have agreed…Fifth Avenue, Suite 4800 700 S. Flower Street, Suite 1000 Seattle, WA 98104 … DTO LAW 700 S. Flower Street, Suite 1000 …2015 13 July 2018 2:15-cv-00522 830 Patent Plaintiff District Court, W.D. Washington…DISBURSE FUNDS - 1 Civil Action No. 15-cv-522MLP ESUP-6-0005P56 StipDisbursement03.docx 172464.1 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Mallinckrodt
Express Scripts
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.